Dr. Ulrich Elling runs an academic research lab at the IMBA in Vienna/Austria. His group is focused on cell identity transitions as well as the development of genetic screening tools. He developed mouse haploid embryonic stem cells as a tool for high throughput genetic screens based on gene trap insertions and chemical point mutagenesis. Recent work focused on improvements of CRISPR/Cas9 as a genetic screening tool. His lab presented CRISPR-UMI, a single-cell tracing method for CRISPR screening to counteract cellular heterogeneity as well as various editing outcomes. The group also published CRISPR-Switch, a tight and rapidly inducible control of sgRNA activity.